You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/tW0boy4CZEmI/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Report Content

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

Thank you for submitting your report

We will investigate and take the appropriate action.

Add to Playlist

Pfizer Execs:"There is a 'Significant Opportunity' to Hike Prices"

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 14:22 UTC on March 17th, 2021.

#pfizer
#vaccine
#covid

TruthVideos1984

subscribers

Your platform for uncensored ideas. BitChute Premium.

BitChute Advertisement

RE-UPLOAD!

Pfizer execs have informed the company's investors of a "significant opportunity" to hike the prices of the Pfizer-BioNTech vaccine.

Speaking at the virtual Barclays Global Healthcare Conference last week, two high-rankin…

RE-UPLOAD!

Pfizer execs have informed the company's investors of a "significant opportunity" to hike the prices of the Pfizer-BioNTech vaccine.

Speaking at the virtual Barclays Global Healthcare Conference last week, two high-ranking Pfizer employees - CFO Frank D'Amelio and Chuck Triano, senior VP of investor relations - said there would be a chance for Pfizer to raise prices for the vaccine when COVID moves from a pandemic state to an endemic situation and the virus circulates continually in pockets around the globe.

Frank D'Amelio: "If you look at how current demand and current pricing is being driven, it's clearly not being driven by what I'll call normal market conditions or normal market forces... it's been driven by the pandemic state we've been in, and the needs of governments to secure doses from various vaccine suppliers."

Download the video:
https://dlsharefile.com/file/ZDIxZWY2NmUt

LESS